05:18 PM EDT, 07/11/2025 (MT Newswires) -- Ryan J. Watts, Director, President and CEO, on July 09, 2025, sold 495,282 shares in Denali Therapeutics ( DNLI ) for $7,429,230. Following the Form 4 filing with the SEC, Watts has control over a total of 2,455,675 common shares of the company, with 253,071 shares held directly and 2,202,604 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1714899/000171489925000149/xslF345X05/wk-form4_1752268398.xml